Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.
A number of genetic alterations are involved in the development of hematologic malignancies. These alterations include the activation of oncogenes by chromosomal translocation or gene amplification and the inactivation of tumor suppressor genes by gene deletion or mutations. Recently, epigenetic change has been proven to be another important means of inactivating tumor suppressor genes in tumor cells, and hypermethylation of promoter DNA is one of the most important mechanisms. In hematologic malignancies, many kinds of tumor suppressor genes and candidate suppressor genes are epigenetically inactivated. Inactivation of tumor suppressor genes usually occurs in a disease-specific manner and plays important roles in the development and progression of the disease. Some of these alterations have clinical effects on treatment results or the prognoses of the patients.
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan. kinosita@med.nagoya-u.ac.jp
Tomohiro
T
Kinoshita
D000818:Animals; D019175:DNA Methylation; D044127:Epigenesis, Genetic / Q000235:genetics; D017353:Gene Deletion; D016147:Genes, Tumor Suppressor; D019337:Hematologic Neoplasms / Q000235:genetics*; D006801:Humans; D009154:Mutation